Showing 721-730 of 856 results for "".
- Lutronic Introduces Accufit for Muscle Stimulationhttps://modernaesthetics.com/news/lutronic-introduces-accufit-for-muscle-stimulation/2473014/Lutronic is launching Accufit, a new device for targeted muscle activation. Eight IntelliSTIM electrodes distribute energy and generate strong muscular contractions on any area needed to be treated without pain or skin sensitivity. Accufit's IntelliPhase waveforms p
- Ransomware Alert: Government Advisory Suggests Threat to Healthcare Systemhttps://modernaesthetics.com/news/ransomware-alert-government-advisory-suggests-threat-to-healthcare-system/2473012/A new advisory coauthored by the Cybersecurity and Infrastructure Security Agency (CISA), the Federal Bureau of Investigation (FBI), and the Department of Health and Human Services (HHS) warns of the potential for ransomware attacks against hospitals and medical systems. “CI
- TrueHero Face Shields Available for Medical Practiceshttps://modernaesthetics.com/news/truehero-face-shields-available-for-medical-practices/2473005/Responding to the need for PPE across the US, Jamestown Plastics, has pivoted production to manufacture face shields to protect from COVID-19. The TrueHero Extreme Coverage Shield is suitable for medical use, including in dermatology and aesthetic practices.
- Suneva, Neauvia Partner to Market and Distribute Plasma IQ in North Americahttps://modernaesthetics.com/news/suneva-neauvia-partner-to-market-and-distribute-plasma-iq-in-north-america-1/2472993/Suneva Medical, Inc., will market and distribute Neauvia Plasma IQ throughout North America as part of a new partnership. The first Class 2 FDA-cleared plasma energy device, Plasma IQ delivers focused, controlled plasma energy to create microinjuries on the skin, renewing
- Gwyneth Paltrow Named Global Face of Xeominhttps://modernaesthetics.com/news/gwyneth-paltrow-named-global-face-of-xeomin-1/2472991/Actress and Goop wellness guru Gwyneth Paltrow is the first global face of Merz Aesthetic’s Xeomin. In this role, Paltrow will be sharing details about what she does to look and feel her best, and will ask women to do the same on social media using #DareToSelfCare. &ldqu
- SoftWave Tissue Regeneration Technologies Announces Plan for Cellulite Trialhttps://modernaesthetics.com/news/softwave-tissue-regeneration-technologies-announces-plan-for-cellulite-trial/2472974/SoftWave Tissue Regeneration Technologies plans to start a 60-patient study to evaluate the safety and efficacy of the DermaGold device for the temporary improvement in the appearance of cellulite. The company has a patent for the use
- NYC Plastic Surgeon Dr. Sachin Shridharani Joins Soliton’s Scientific Advisory Boardhttps://modernaesthetics.com/news/sachin-shridharani-md-joins-solitons-scientific-advisory-board/2472973/Sachin Shridharani, MD has joined Soliton, Inc’s Scientific Advisory Board. Soliton, Inc. recently filed for 510(k) premarket clearance with the U.S. Food and Drug Administration (FDA) of its second-generation Rapid Acoustic Pulse (RAP) device for the reduction in the appearance o
- Online Consults On the Rise; Credentials Matterhttps://modernaesthetics.com/news/online-consults-on-the-rise-credentials-matter/2472967/The British Association of Aesthetic Plastic Surgeons (BAAPS) is reporting a “massive upswing” in demand for virtual consultations during lockdown, but urges the public to remain cautious. Despite predicted financial strains being felt acro
- New from Cutera: Get to Know Fraxis PROhttps://modernaesthetics.com/news/new-from-cutera-get-to-know-fraxis-pro/2472965/Cutera, Inc. is launching Fraxis PRO progressive dermal remodeling technology. Fraxis PRO combines fractional CO2 for skin resurfacing and radiofrequency microneedling for dermal remodeling in a single device. Fraxis PRO treats: Fine Lines Wr
- Industry Vet Didier Leclercq Joins Aerolase Leadership Teamhttps://modernaesthetics.com/news/industry-vet-didier-leclercq-joins-aerolase-leadership-team/2472958/Didier Leclercq is Aerolase’s new Vice President of Global Market Development. Prior to his role as Managing Director of the SHIELD innovation center of Nestlé Skin Health/Galderma, Mr. Leclercq ran Q-Med onc